Text Size
14 studies found for:    "Epidermolysis Bullosa Dystrophica" OR "dystrophic epidermolysis bullosa"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
2 Recruiting Characteristics of Patients With Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
3 Recruiting Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
4 Recruiting Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Drug: Granulocyte Colony Stimulating Factor (GCSF)
5 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
6 Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
7 Terminated Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
8 Terminated
Has Results 		Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
9 Recruiting Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Interventions: Drug: Polyphenon E before Placebo;   Drug: placebo before treatment
10 Recruiting Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Interventions: Device: Helicoll;   Device: Standard of Care Dressings
11 Not yet recruiting Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Recessive Dystrophic Epidermolysis Bullosa
Interventions: Other: Blood collection;   Other: Skin biopsies
12 Active, not recruiting Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa
Intervention: Drug: Reduced Intensity Transplant conditioning
13 Unknown † Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: isotretinoin
14 Terminated
Has Results 		Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation
To Top

† Indicates status has not been verified in more than two years